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 Abstract: Background: The discovery of new chemotherapeutic agents still remains a continuous 
goal to achieve. DNA polymerases and topoisomerases act in nucleic acids metabolism modulating 
different processes like replication, mitosis, damage repair, DNA topology and transcription. It has 
been widely documented that Polymerases serve as molecular targets for antiviral and antitumoral 
chemotherapy. Furthermore, telomerase is a ribonucleoprotein with exacerbated activity in most of the 
tumor cell lines, becoming as an emergent target in Cancer treatment.  
Methods: We undertook an exhaustive search of bibliographic databases for peer-reviewed research 
literature related to the last decade. The characteristics of screened bibliography describe structure ac-
tivity relationships and show the principal moieties involved. This work tries to summarize the inves-
tigation about natural and semi-synthetic products with natural origin with the faculty to inhibit key 
enzymes that play a crucial role in DNA metabolism. 
Results: Eighty-five data references were included in this review, showing natural products widely 
distributed throughout the plant kingdom and their bioactive properties such as tumor growing inhibi-
tory effects, and anti-AIDS activity. 
Conclusion: The findings of this review confirm the importance to find new drugs and biologically 
active natural products, and their potential medicinally useful benefits. 
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1. INTRODUCTION 
Natural products and their derivatives have been used for 
a long time in traditional medicine. In addition to their low 
cost and wide practice, natural products and their derivatives 
attract growing interests and are valuable resources for drug 
design and pharmaceutical development. Plants have a long 
history of use in the treatment of cancer. Scientists have 
identified many molecules with anticancer activities from 
nature, including taxol, vinblastine, camptothecin, paclitaxel, 
cephalotaxine, matrine, and colchicine [1-4]. 
Chemotherapy remains to be the standard treatment for 
initial or advanced stages of cancer. However, commonly 
used chemotherapeutic agents may induce damage in healthy 
cells or tissues. Thus, in recent years, there has been an in-
creased effort in the development of new, efficient anticancer 
drugs exhibiting low toxicity, that are not affected by mech-
anisms of chemo-resistance [5-7]. 
Complexity and molecular diversity, high selectivity and 
specific biological activities are characteristics of natural 
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products, and many of these metabolites have some receptor-
binding activity in a specific manner [8]. Consequently, 
some proteins can become true molecular targets and then 
develop certain pharmacological action. One kind of targets 
could be DNA-related enzymes. These receptors play a cru-
cial role in DNA metabolism, including processes such as 
recombination, replication, transcription and chromosome 
segregation during cell division. The inhibition of these al-
low the development of new leads, like antitumoral and anti-
viral agents. Considering the enormous complexity and 
structural diversity of natural products, we can find alka-
loids, chalcones and flavonoids, iridoids, polyalcohols, lipids 
and terpenoids, macrocycles, quinones, and polyphenols 
capable of showing this activity, but with the accuracy of 
maintaining a defined configuration of its chiral centers. This 
work tries to summarize the investigation about some re-
markable natural and semi-synthetic products that share a 
natural origin, with the ability to inhibit key DNA-related 
enzymes [9, 10]. 
2. DNA POLYMERASES 
DNA polymerases are ubiquitous enzymes with the abil-
ity to create new polymers of deoxyribonucleic acid from 
four different kinds of subtracts, known as nitrogenous DNA 
bases. These proteins, together with different topoisomerases 
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and helicases, play a crucial role in DNA metabolism, such 
as recombination, replication, transcription, and chromosome 
segregation during meiosis and mitosis. Hyperproliferative 
diseases such as cancer, autoimmune conditions, and vi-
ral/bacterial infections are associated with uncontrollable 
DNA replication. For this reason, it has long been accepted 
that these enzymes are important molecular targets for the 
development of cancer and antiviral chemotherapeutic agents 
[11-17].  
In the subsequent paragraphs, some natural products and 
derivatives with DNA polymerase inhibitory activity are 
categorized according to their chemical structures. 
2.1. Flavonoids and Chalcones 
The flavonoid group comprises a large family of plant-
derived polyphenolic compounds of medium to low molecu-
lar weight, which exhibit diverse biological activities. The 
naturally occurring chalcones, or benzopyrone derivatives, 
and the phenylchromones are widely distributed throughout 
the plant kingdom as components in fruits, vegetables, tea, 
bark, roots, flowers, grains, etc. [18, 19]. 
Myristinin is a bioflavonoid isolated from Myristica cin-
namomea [20]. This occurs as different stereoisomers known 
as myristinin A and myristinin B/C. In 2004, Maloney and 
co-authors prepared (+)-myristinin stereoselectively with 
absolute stereochemistry. In addition to DNA-damaging abil-
ity, (+)-myristinin was also shown to inhibit DNA polymer-




Fig. (1). Chemical structure of (+)-myristin. 
Another kind of non-glycosylated flavonoids able to in-
hibit DNA polymerase β was 5-methoxyflavone. The three-
ringed molecular scaffold of this flavone is easy to synthe-
size in the development of nature-inspired compounds (Fig. 
2) [22].  
 
 
Fig. (2). Chemical structure of 5-methoxyflavone. 
Drugs with low molecular weight have usually shown a 
good ability to cross cell membranes by passive diffusion, 
such as the nuclear membrane. Furthermore, simple alkylat-
ed flavonoids have shown selective pharmacological proper-
ties, such as xanthohumol. This prenylated chalcone exhibit-
ed remarkable inhibitory activities against human DNA pol-
ymerase α (Fig. 3) [23].  
 
 
Fig. (3). Chemical structure of xanthohumol. 
It should be noted that the use of more complex struc-
tures increases the probability of improving the physical-
chemical interactions between molecules and receptors. In 
this case, biflavonoids from Dacrydium balansae have 
shown a potent inhibition of the Dengue virus NS5 RNA-
dependent RNA polymerase (Fig. 4) [24].  
 
 
Fig. (4). Chemical scaffold of a kind of active biflavonoid. 
Although the receptor used is not specifically a DNA-
dependent polymerase, it would be interesting to conduct a 
study on this kind of enzyme using flavonoid dimers. The 
use of duplicate molecular scaffolds, in addition to favoring 
greater structural complexity, generally leads to a better cel-
lular permeability through passive diffusion mechanisms, 
which results from a greater hydrophobicity [25]. 
2.2. Lipids and Terpenoids 
Lipids represent a class of metabolites with interesting 
values of cLogP mainly due to their hydrocarbon constitu-
tion. These can be made as different forms: from molecules 
with very low molecular weight to complex structures with 
more than 100 carbon atoms like dolichol. Terpenes are sec-
ondary metabolites derived from a unit of five-carbon atoms 
called isoprene, thus sharing different building blocks of this 
[26-29]. 
The first attempts to discover β-polymerase inhibitors 
conducted by Mizushina et al. revealed that long chain fatty 
acids suppressed polymerase activity [30]. They also found 
that terpeno-benzoic acids, from the plant Myrsine seguinii, 
showed an inhibitory effect against enzymes involved in 
DNA synthesis, such as calf DNA polymerase α (pol. α), rat 
DNA polymerase β (pol. β) and one of the β family polymer-
ases, calf thymus terminal deoxynucleotidyl transferase 
(TdT). Its IC50 values were 22 µM for pol. α, 11 µM for pol. 
β, and 46 µM for TdT, respectively (Fig. 5) [31]. These au-
thors suggested that the presence of carboxylic acid is an 
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Fig. (5). Chemical structure of a terpeno-benzoic acid from Myrsine 
seguinii. 
Another class of attractive lipid carboxylic acid which 
has shown this activity is 7,8-euphadien, a type of triterpe-
noid from Brackenridgea nitida and Bleasdalea bleasdalei. 
This product inhibited rat DNA polymerase α with an IC50 
value of 23 µM in the presence of bovine serum albumin 
(BSA) and 9.7 µM in the absence of BSA (Fig. 6) [32]. 
 
 
Fig. (6). Chemical structure of 7,8-euphadien. 
Furthermore, bioassay-guided fractionation of extracts 
prepared from Couepia polyandra and Edgeworthia gardneri 
resulted in the isolation of the DNA polymerase β inhibitors, 
oleanolic acid (IC50 = 24.98 ± 3.3 µM) and betulinic acid 
(IC50 = 46.25 ± 3.1µM), (Fig. 7) [33]. 
 
 
Fig. (7). Chemical structure of oleanolic and betulinic acids. 
2.3. Iridoids and Other Polyalcohols 
Iridoids, glycosides and other polyalcohols display an el-
evated content of oxygen, giving these molecules high water 
solubility. Their poor lipophilicity might account for the lack 
of biological activity against human solid tumor cell lines. 
This may appear, in principle, to be a disadvantage when 
crossing lipid membranes; but the presence of hydroxyl 
groups increases the probability of direct enzyme recognition 
through hydrogen bonds [34-36]. 
Iridoids may even emulate the nitrogenous substrates of 
DNA-related enzymes. The bicyclic aglycone of DNA pol-
ymerase inhibitor catalpol could mimic the purine scaffold 
present in natural nucleosides because they share similar 
electronic surface distribution (Fig. 8) [37]. 
In 2010, our research group synthesized a novel catalpol 
derivative able to inhibit the KlenTaq fragment. By conduct-
ing molecular dynamic studies, we proposed a recognition 
inside the catalytic site by hydrogen bonds between glyco-
sidic hydroxyls and polar chain residues (Fig. 9) [36]. 
 
 
Fig. (8). Conformational structure of a catalpol derivative. 
 
 
Fig. (9). Chemical structure of 6,10,2´,6´-tetraacetyl-O-catalpol. 
Furthermore, Pungitore et al. prepared a series of novel 
lipophilic catalpol analogs by the regioselective addition of 
silylether moieties. Antimetabolites cannot enter cells easily 
by passive diffusion due to their low lipophilicity. However, 
these products did show antitumoral activity, possibly due to 
their higher cLogP values (Fig. 10) [38]. 
 
 
Fig. (10). Chemical structure of a lipophilic catalpol derivative. 
Recently, Garro et al. isolated a new epimer iridoid of ca-
talpol from Buddleja cordobensis [39]. This metabolite was 
even more active than catalpol. Similarly, two silylether de-
rivatives with higher lipophilicity also showed inhibition. 
Considering a different configuration of carbon six, the ac-
tivity may improve; and hydrophobic derivatives could act 
against human solid tumors (Fig. 11).  
From Buddleja cordobensis, we also could isolate ver-
bascoside as a per-O-acetyl derivative. This disaccharide has 
shown to be a potent inhibitor with IC50 = 1.21 µM, possibly 
due to its complex structure and the large number of chiral 
centers (Fig. 12). 
Finally, the natural polyalcohol petasiphenol, extracted 
from the Japanese plant Petasites japonicus, was shown to 
selectively inhibit pol λ activity, but it resulted to be inactive 
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towards the structurally-related polymerase β, as well as to-
wards replicative polymerases (Fig. 13). Petasiphenol inhib-
ited the pol λ activity indirectly by acting at the BRCT (C-
terminal domain of a breast cancer susceptibility protein), 
and could not recognize the BRCT domain structure of other 
proteins, suggesting that the three-dimensional structure of 
the BRCT domain of pol λ differs of pol β [40]. 
 
 




Fig. (12). Chemical structure of per-O-acetyl-verbascoside. 
 
 
Fig. (13). Chemical structure of petasiphenol. 
3. TELOMERASE 
Telomeres are repetitive DNA elements at the end of 
chromosomes that protect against chromosomal erosion and 
rearrangement inside the nucleus. This unique structural 
formation of DNA is different from the well-known helical 
structure that DNA adopts. Furthermore, it has recently been 
proposed as a molecular target for new kinds of anticancer 
agents, in particular, molecules able to stabilize the intramo-
lecular G-quadruplex. Telomerase is part of an enzyme com-
plex that counteracts telomeres shortening. This protein is 
constituted by the catalytic subunit telomerase reverse tran-
scriptase (TERT) and its RNA component sequence [41, 42].  
Human telomeres are simple (TTAGGG)n islands of 5–
15 kb repeated sequences located at the ends of chromo-
somes. This structure capping the chromosome termini pre-
vents aberrant recombination. The mutagenesis events 
caused by these aberrant changes could eventually result in a 
malignant cell differentiation. Highly proliferative cells re-
quire elevated levels of telomerase activity to offset such loss 
of telomeric DNA. This enzyme has become an obligatory 
objective for anti-cancer research, as it promised a unique 
target for chemotherapy without the related side effects of 
conventional chemotherapeutics [43, 44]. As an anticancer 
strategy, efforts have been invested in targeting and lowering 
telomerase activity, which is frequently found to be overex-
pressed in cancerous cells [45]. 
3.1. Alkaloids 
Quinoline compounds are characterized by a double-
ringed structure that contains a benzene ring fused to a het-
erocyclic aromatic nitrogen pyridine. These products have 
shown strong inhibition with sub-toxic concentrations, such 
as 11-substituted cryptolepine analogs (Fig. 14). 
 
 
Fig. (14). Chemical structure of 11 substituted quindolines. 
In 2005, Zhou et al. demonstrated its capacity to stabilize 
a G-quadruplex, and that an electron-donating substituent at 
the 11-position can enhance the basicity of the nitrogen at-
om, thus increasing the electrostatic interaction between the 
derivatives and the negative electrostatic center of the G-
quadruplex [46, 47]. 
In the last decade, Neidle’s and Huang`s groups reported 
that 13 and 9-substituted berberine derivatives had the ability 
to selectively bind to G-quadruplex over double-stranded 
DNA, including those present in the human oncogene c-myc 
sequence (Fig. 15) [48, 49].  
 
 
Fig. (15). Chemical structure of 9 substituted berberine analogs. 
Overexpression of this oncogene is related to the increase 
of cellular and malignant proliferation. Guanine rich se-
quences present in its promoter region controls 80-90% of 
the transcription activity of c-myc. Several small molecules, 
like chelerythrine, which can stabilize this quadruplex struc-
ture, are putative agents to downregulate c-myc expression 
(Fig. 16). Interestingly, the protonated iminium form of chel-
erythrine is able to intercalate into double stranded DNA 
[50]. 
Electrospray ionization mass spectrometry (ESI–MS) and 
Circular Dichroism (CD) can be used to determine the for-
mation and recognition of human telomere G-quadruplex and 
selectivity versus duplex DNA. For example, the binding of 
homobarringtonie, a natural alkaloid with a seven-membered 
heterocycle, was established using these methods (Fig. 17) 
[51]. 
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Fig. (17). Chemical structure of homobarringtonie. 
3.2. Porphyrins and Perylene Compounds 
Polycyclic aromatic hydrocarbons (PAHs) are a large 
group of hydrophobic chemicals, characterized by presenting 
conjugate systems within a planar geometry [52]. Some por-
phyrin derivatives bearing N-methylpyridinium cationic side 
arms are able to bind with parallel four-stranded (TG4T)4 G-




Fig. (18). Chemical structure of porphyrin derivatives bearing N-
methylpyridinium cations. 
Perylenes and coronenes are hydrosoluble PAHs able to 
recognize and specific binding of telomeric G-quadruplexes. 
These compounds contain a large planar aromatic system 
moiety, which can bind to the terminal G-quartet of a G-
quadruplex via π−π* stacking in a threading intercalation 
mode. For example, Franceschin et al. prepared four “not 
self-aggregated” perylene derivatives with activities lower 
than 20 µM of telomerase inhibition (Fig. 19).  
The most interesting point was the strong inhibition and 
the water solubility of these, which suggest a potential low 
toxicity [54]. The same group of researchers also prepared 
coronene derivatives capable of specifically recognizing sec-
ondary structures of G-quadruplex (Fig. 20) [55]. 
 
Fig. (19). Chemical structure of a perylene derivative. 
 
 
Fig. (20). Chemical structure of a coronene derivative. 
3.3. Quinones 
Quinones containing compounds have been widely used 
for their antitumour activity. Nature is an important source of 
novel quinone analogues, such as para and ortho-
benzoquinones, naphthoquinones and anthraquinones. Al-
most 350 natural naphthoquinones have been discovered. 
Now, the co-existence of naphthoquinones and anthraqui-
nones in plants is not atypical, and they have a common pre-
cursor. New types include isofuranonaphthaquinones and 
naphthoquinones linked to coumarin, which form substantial 
subgroups with interesting activities [56]. For example, 
celastrol a quinone methide triterpenoid from the Chinese 
medicinal root bark of Tripterygium wilfordii, possesses 
beneficial therapeutic properties. A series of celastrol deriva-
tives were prepared as potential telomerase inhibitors, show-
ing a direct correlation between telomerase inhibition and 
anti-proliferative inhibition of SMMC-7721 in human hepa-
toma cells. This compound with hydrophilic moieties show 
potential non-toxic side effects (Fig. 21) [57, 58].  
 
Fig. (16). Chelerythrine forms. 
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Fig. (21). Chemical structure of a hydrophilic celastrol derivative. 
The tanshinone natural products have a variety of phar-
macological properties including, anti-neoplastic activity. 
Ortho-quinone containing tanshinones were telomerase in-
hibitors through an oxidative mechanism mediated by pro-
duction of hydrogen peroxide. To examine the importance of 
the ortho-quinone moiety, Soares et al. examined the te-
lomerase inhibition by telomerase inhibitors and the simple 
ortho-quinone 9,10-phenanthrenequinone (PHQ). They 
found out that the ortho-quinone tanshinone Tan II-A and 




Fig. (22). Chemical structures of an ortho-quinone tanshinone (left) 
and 9,10-phenanthrenequinone (right). 
Rubromycins are a family of structurally related com-
pounds originally isolated from Actinomycetes that exhibit an 
attractive array for pharmacology (Fig. 23). Telomerase is a 
dimeric protein consisting of two reverse transcriptase motifs 
(TERT) with two RNA components (TR). β-rubromycin has 
revealed a competitive interaction with the telomerase sub-
strate primer interacting both with the human telomerase 
RNA (TR) and the catalytic subunit (TERT), (IC50 = 3.06 
µM) [60].  
 
 
Fig. (23). General scaffold of rubromycins. 
It was established that the high biological activity of 
rubromycin compounds significantly depends on the pres-
ence of the [5,6]-bisbenzannulated spiroketal moiety as a 
central structural motif. An elegant synthesis of (±) γ-
rubromycin was made by Michael Wilsdorf and Hans-
Ulrich Reissig, opening novel and challenging methods 
(Fig. 24) [61, 62]. 
 
 
Fig. (24). Chemical structure of (±)-γ-rubromycin. 
4. TOPOISOMERASE 
Another vital enzymes implicated in the replication, tran-
scription, recombination or DNA repair processes are the 
topoisomerases [63, 64]. These proteins direct and supervise 
the topological arrangement and orientation of DNA by re-
laxing torsion stress in supercoiled DNA sectors [65].  
There are two major classes of topoisomerases, that share 
common characteristic, considering the nicking mechanism. 
Enzymes that cleave one strand of the DNA double strand 
are defined as topo I class; isoforms that cleave both strands 
are catalogued as topo II proteins [66, 67]. Topo I produces 
the relaxation of DNA chain during replication by a single 
strand break in DNA. The single strand break is then relegat-
ed, thus restoring the DNA double strands, without any ener-
gy cofactor [68].  
Today, in clinical and medical practice, mammalian 
DNA topoisomerases are considered prominent cellular tar-
gets of several anti-cancer drugs [69]. Perhaps, camptothecin 
analogues are the most topoisomerase inhibitors used; how-
ever, another kind of natural products are promising candi-
dates. 
4.1. Lipids and Terpenes 
Mizushina et al. reported that some triterpenes are able to 
inhibit human topoisomerase II and some DNA polymerases. 
Remarkably, topo II and polymerase β have a similar three-
dimensional triterpene-binding region, which is a hydropho-




Fig. (25). Chemical triterpene scaffold from plant callus tissues of 
some Chinese medicinal plants. 
Moreover, the hydroxyl moiety at “A ring” might gener-
ate a weaker inhibitory activity, but not the carboxyl group. 
This acidic group could have the required electronic density 
surface with the rest of terpene scaffold necessary for such 
inhibition.  
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Moreover, Guo-Wei Wang et al. have isolated new 




Fig. (26). Chemical structures of some lanostane-triterpenoids from 
Abies faxoniana. 
Three of them have shown activity, and they share the car-
boxylic moiety at the end of the macrocyclic terpene structure. 
Interestingly, the fourth active compound shows a lactone 
moiety instead of the carboxylic residue, showing the best IC50 
values. These chemically related groups share approximately 
the same van der Waals surface for each arrangement. How-
ever, the lactone group show a higher probability to insert 
inside of terpene topo hydrophobic pocket [71].  
Another kind of derivatives bearing α,β-unsaturated lac-
tone are gibberellins. These potent topoisomerases I inhibi-
tors belong to the tetracyclic diterpenes and show attractive 
cLogP values (Fig. 27) [72]. 
 
 
Fig. (27). Chemical structure of a gibberellin hydrophobic ana-
logue. 
4.2. Alkaloids 
Fagaronine has been shown to interact inside of DNA, as 
well as with double stranded regions of ribonucleic acids, 
like tRNA (Fig. 28). As a cytotoxic agent, its activity seems 
to depend on the presence of the quaternary nitrogen because 
the desmethyl congener was inactive [73, 74]. 
Berberine salts analogues show a slightly buckled struc-
ture due to the partial saturation of the central ring. Berberine 
has been previously characterized as a DNA intercalating 
agent and as a cationic ligand, and electrostatic forces could 
play an important role in its interaction with DNA phos-
phates. Furthermore, electric linear dichroism experiments 
have shown that burasaine also interacts with DNA minor 
groove in an intercalation mode of binding (Fig. 29) [75]. 
 
 
Fig. (28). Chemical structure of fagaronine. 
 
 
Fig. (29). Chemical structure of burasaine. 
Theoretical simulations using molecular docking studies 
have shown that these planar compounds bound with topoi-
somerase/DNA complex, mainly through π–π stacking inter-
actions [76]. 
Last year, Ashish Kumar et. al isolated a protoberberine 
group of isoquinoline alkaloids from Thalictrum foliolosum, 
including thalifendine and berberine. Surprisingly, they 
could find two new bisbenzylisoquinoline alkaloids. One of 
them displayed potent inhibitory activity against topoisomer-
ase I in a concentration dependent manner (Fig. 30). Appar-
ently, it did not stabilize enzyme/DNA covalent complex, 
acting as a class II inhibitor, which is a catalytic inhibitor of 
the enzyme [77]. 
 
 
Fig. (30). Chemical structure of a bisbenzylisoquinoline alkaloid 
isolated from Thalictrum foliolosum. 
Finally, β-carboline alkaloids represent a promising class 
of antitumoral drugs. Galianthe thalictroides (Rubiaceae), is 
a widespread shrub in Argentina, Brazil, Paraguay, and Uru-
guay, where it is popularly used to treat and prevent Cancer. 
A new cytotoxic β-carboline alkaloid from its roots, 1-
methyl-3-(2-hydroxypropan-2-yl)-2-(5-methoxy-9H-β-
carbolin-1-yl) cyclopentanol, inhibited both topoisomerase I 
and topoisomerase II α better than etoposide, in a tested con-
centration of 1 µM (Fig. 31) [78, 79]. 
4.3. Flavonoids and Chalcones 
Flavonoids are widely spread in the plant kingdom and 
are common constituents of vegetables, fruits, and certain 
beverages. In 2010 López-Lázaro et al. evaluated the effects 
of four common dietary flavonoids (quercetin, apigenin, 
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fisetin and myricetin) on topoisomerases at several concen-
trations using a cell-based assay (Fig. 32) [80, 81].  
 
 




Fig. (32). Chemical structures of some common dietary flavonoids. 
They found that, in addition to the cancer preventive ef-
fects showed by some flavonoids, at higher concentrations 
(micromolar), these products may induce topoisomerase-
mediated DNA alterations that might have carcinogenic ef-
fects. This denotes the importance of finding more selective 
and active inhibitors at low concentrations. 
Furthermore, quercetin diacylglycoside analogues have 
shown interesting activities against bacterial DNA gyrase 
and topoisomerase IV (Fig. 33). These compounds could be 
interesting for the study against human topoisomerases using 
a more rational design [82]. 
 
 
Fig. (33). Chemical scaffold of a quercetin diacylglycoside ana-
logue. 
The acyl glycoside present in flavonoids products seems 
to be an attractive moiety for activity. For example, a 
kaempherol glycoside derived from parts of two unique vari-
eties of the Leguminosae, Vicia faba and Lotus edulis from 
Crete acted as catalytic inhibitor of wheat germ topoisomer-
ase I and human topoisomerases I and II (Fig. 34) [83]. 
 
 
Fig. (34). Chemical structure of 2, kaempferol 3-O-(5-O-acetyl-α-
D-apiofuranosyl)-7-O-α-L-rhamnopyranoside. 
Finally, using the chalcone scaffold as starting material, 
interesting families of inhibitors can be achieved by simple 
preparation methods; for example, by incorporating het-
eroaromatic cyclopropane rings (Fig. 35) [84, 85].  
 
 
Fig. (35). Chemical scaffold of chalcone derivatives. 
CONCLUSION 
Several of the essential molecular mechanisms underly-
ing malignant tumor biology remain still elusive and, thus, 
developing specific anticancer therapies remains a challenge. 
Medicinal plants and their natural products possess numer-
ous bioactive principles which attack multiple targets, show-
ing minor side effects, low potential to cause resistance, and 
remarkably low costs of production. The idea of DNA repli-
cation or DNA-repair interference as a potential tool ap-
proach to overcome intrinsic or acquired tumor resistance is 
gaining substantial attention. With respect to the inhibition of 
DNA repair pathways, it is desirable to avoid hurting normal 
cells. 
Polymerases have a highly preserved structure, which 
means that their overall catalytic subunits motifs fluctuate 
very little from species to species. A preserved structure usu-
ally indicates that the protein has a crucial, irreplaceable 
function in the cell, the maintenance of which provides evo-
lutionary advantages.  
Telomerases are distinguished by having a particular cat-
alytic activity from which RNA sequences can be employed 
as a template in a retro-transcription process. This feature 
could use reverse transcriptase inhibitors as potential te-
lomerase inhibitors, thus increasing selectivity and specifici-
ty.  
Topoisomerases are a special class of enzymes that do 
not require enzymatic cofactors or external energy to carry 
out their action. However, since its main function focuses on 
relieving DNA topology, and certain secondary structures, 
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topoisomerases tend to have an affinity for the recognition of 
conjugated planar molecules, which can be found in nature. 
Various products of natural origin and derivatives are 
useful pharmacological agents, but the search for new anti-
tumoral and antiviral drugs remains still necessary. 
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